International travel volumes are recovering after the COVID-19 pandemic. We highlight the high risk of malaria for travellers to sub-Saharan Africa and the continued need for health practitioners to prescribe and facilitate access to affordable antimalarial chemoprophylaxis and to provide high-quality diagnostic services and therapeutic care for case management.